Relafen 750, the unique preparation of naproxen, offers a intriguing example from a biochemical pharmacy perspective. This mode of action, essentially involving blocking of check here cyclooxygenase enzymes – COX-1 and COX-2 – leads to significant decrease in prostaglandin synthesis. From our biochemical lens, the drug's potency is closely rela